Results of the combined general meeting of 28 june 2024

Lyon (france) and cambridge (ma, us), 28 june 2024 - 5.45 pm cest - phaxiam therapeutics (euronext: phxm; fr0011471135), a biopharmaceutical company developing innovative treatments for severe and resistant bacterial infections, announces the results of the shareholder vote following the combined general meeting held today, 28 june 2024, at the head office, located 60 avenue rockefeller, 69008, lyon.
GM Ratings Summary
GM Quant Ranking